Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter C. Enzinger, M.D.

Concepts (294)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Peter Enzinger's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Peter Enzinger has written about over time.
Camptothecin, 17 publications between 1998 and 2017, average publication date September 2008. Carcinoma, Squamous Cell, 10 publications between 1999 and 2023, average publication date September 2011. Cisplatin, 16 publications between 1998 and 2022, average publication date May 2012. Fluorouracil, 23 publications between 2000 and 2024, average publication date February 2013. Antineoplastic Combined Chemotherapy Protocols, 56 publications between 1999 and 2024, average publication date May 2014. Adenocarcinoma, 43 publications between 1999 and 2024, average publication date October 2014. Esophageal Neoplasms, 45 publications between 1999 and 2024, average publication date December 2015. Stomach Neoplasms, 33 publications between 2004 and 2024, average publication date September 2017. Esophagogastric Junction, 20 publications between 2005 and 2024, average publication date October 2019. Receptor, ErbB-2, 5 publications between 2020 and 2024, average publication date September 2022. Platinum, 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Enzinger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (294)
Explore
_
Co-Authors (119)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.